Closed
SectorHealthcare
11.22 0.27
24h
Min
11.11
Max
11.24
Income | 212M 25M |
---|---|
Sales | 4.5M 9M |
EPS | -0.218 |
Profit margin | 280.018 |
Employees | 750 |
EBITDA | -52M -274M |
Recommendations | Strong Buy |
---|---|
12 Months Forecast | +42.86% upside |
Market Cap | 7.6B |
---|---|
Previous open | 10.95 |
Previous close | 11.22 |
By Acuity
50%
50%
166 / 380 Ranking in Healthcare
By Trading Central
Confidence
Weak Bullish Evidence
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Price change
By TipRanks
12 Months Forecast
Average 16 USD 42.86%
High 18 USD
Low 12 USD
Based on 7 Wall Street analysts offering 12 month price targets forRoivant Sciences Ltd - Dist in the last 3 months.
By Acuity
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Below average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$